How an Activist Group Helped Torpedo MDMA Therapy
Posted inClinical Trials Drugs (Pharmaceuticals) Ethics and Official Misconduct Food and Drug Administration Institute for Clinical and Economic Review Lykos Therapeutics Mental Health and Disorders Multidisciplinary Assn for Psychedelic Studies Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Psymposia Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

How an Activist Group Helped Torpedo MDMA Therapy

The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
FDA Panel Rejects Use of MDMA for Treatment of PTSD
Posted inDrug Abuse and Traffic Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration Institute for Clinical and Economic Review Justice Department Lykos Therapeutics Medicine and Health Mental Health and Disorders Multidisciplinary Assn for Psychedelic Studies Placebos Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Therapy and Rehabilitation Veterans

FDA Panel Rejects Use of MDMA for Treatment of PTSD

An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
FDA Panel Weights MDMA Therapy for PTSD
Posted inDrug Abuse and Traffic Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration Lykos Therapeutics Mental Health and Disorders Multidisciplinary Assn for Psychedelic Studies Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Regulation and Deregulation of Industry

FDA Panel Weights MDMA Therapy for PTSD

An independent group of experts is meeting Tuesday to consider whether to allow use of this illegal drug, also known as Ecstasy, to treat PTSD.